Source: Web Search Revision Year: 2022 Publisher: FAES FARMA, S.A., Máximo Aguirre, 14, 48940 – Leioa, Spain
Mecolzine 500 mg suppositories.
| Pharmaceutical Form |
|---|
|
Suppository. Torpedo-shaped suppository with greyish-white to slightly violet-reddish color. |
Each suppository contains 500 mg of mesalazine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mesalazine |
Mesalazine is an aminosalicylate. The mechanism of action of mesalazine is not fully understood, but appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon. |
| List of Excipients |
|---|
|
Hard fat. |
Suppositories are packaged in PVC/PE strips.
Each pack contains 12, 24, 60 and 100 suppositories.
Not all pack sizes may be marketed.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
FAES FARMA, S.A., Máximo Aguirre, 14, 48940 – Leioa, Spain
MA1278/00301
Date of first authorization: 20-10-2020
| Drug | Countries | |
|---|---|---|
| MECOLZINE | Cyprus, Ecuador, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
